Case-control study shows cfDNA methylation markers enhance detection and prognosis in gastric cancer, indicating possible clinical utility.
Our study highlights the potential utility of cfDNA methylation markers for both the detection and prognostication of GC.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: